EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing viral footprints in circulating free DNA ( cfDNA ) for early cancer detection: A focus on liquid‐biopsy‐based screening

Richard Donkor Amponsah iD, Emmanuel Addai Gyabaah iD, Moro Amidu, Zhao Cheng iD, Fazlur Rahman Talukdar iD

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70121 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Richard Donkor Amponsah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, University of Ghana Medical School, Accra, Ghana. Hauptthemen laut MEDLINE: Early Detection of Cancer, Neoplasms, Cell-Free Nucleic Acids, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral infections play a significant role in cancer development, making detecting viral signatures a promising approach for early cancer diagnosis. Circulating free DNA (cfDNA), released into the bloodstream by tumors and other cells, has emerged as a powerful biomarker for non‐invasive cancer screening. This review explores the potential of cfDNA in detecting virus‐associated cancers through the analysis of viral footprints. It provides a comprehensive overview of the biological mechanisms underlying cfDNA release, the role of oncogenic viruses in cancer progression, and the unique viral markers that can be traced within cfDNA. By leveraging viral genetic material, cfDNA analysis offers transformative potential for the early detection of virus‐driven malignancies. Highlighting its clinical relevance, this review discusses how cfDNA‐based viral biomarker screening could significantly enhance cancer monitoring, improve prognosis accuracy, and pave the way for innovative, non‐invasive diagnostic tools and personalized cancer management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerNeoplasmsCell-Free Nucleic AcidsBiomarkers, TumorDNA, ViralHumansLiquid BiopsyOncogenic VirusesCirculating Tumor DNA

Stichwörter der Autor:innen

circulating free DNA (cfDNA)early cancer detectionliquid biopsyoncogenic virusesvirus‐associated cancers

Substanzen

Cell-Free Nucleic AcidsBiomarkers, TumorDNA, ViralCirculating Tumor DNA

Autor:innen und Institutionen

  • Department of Medical Microbiology, University of Ghana Medical School, Accra, Ghana.
  • Department of Biochemistry & Biotechnology, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana.
  • Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
  • Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK.

ORCID-Profile: Richard Donkor Amponsah, Emmanuel Addai Gyabaah, Zhao Cheng, Fazlur Rahman Talukdar

Zitieren

APA

Amponsah, R. D., Gyabaah, E. A., Amidu, M., Cheng, Z., & Talukdar, F. R. (2026). Harnessing viral footprints in circulating free DNA ( cfDNA ) for early cancer detection: A focus on liquid‐biopsy‐based screening. International Journal of Cancer. https://doi.org/10.1002/ijc.70121

Vancouver

Amponsah RD, Gyabaah EA, Amidu M, Cheng Z, Talukdar FR. Harnessing viral footprints in circulating free DNA ( cfDNA ) for early cancer detection: A focus on liquid‐biopsy‐based screening. International Journal of Cancer. 2026. doi:10.1002/ijc.70121

BibTeX
@article{Amponsah2026,
  author = {Amponsah, Richard Donkor and Gyabaah, Emmanuel Addai and Amidu, Moro and Cheng, Zhao and Talukdar, Fazlur Rahman},
  title = {Harnessing viral footprints in circulating free DNA ( cfDNA ) for early cancer detection: A focus on liquid‐biopsy‐based screening},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70121}
}
Kostenlos starten →